 with thrombolytic agents (RR,
1.73; 95% CI 1.04-2.88) but no significant differences in
mortality (RR, 0.84; 95% CI, 0.29-2.42), pulmonary embolism (RR, 1.23; 95% CI, 0.34-4.45), or intracranial
